Chronic and paroxysmal atrial fibrillation: Course, prognosis, and stroke risk

Journal of Thrombosis and Thrombolysis

Volumn 7, Issue 1, 1999, Pages 7-11

  Cuddy, T Edward ^a  

^a HEALTH SCIENCES CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DISEASE COURSE; HEART ATRIUM FIBRILLATION; MORTALITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; STROKE;

ATRIAL FIBRILLATION; CEREBROVASCULAR DISORDERS; CHRONIC DISEASE; HUMANS; RISK; RISK FACTORS;

EID: 0032994894     PISSN: 09295305     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008803800895     Document Type: Article

References (49)

1. Cushny AR, Edmunds CW. On the interpretation of pulse tracings. Exp Med 1899;4:327.
2. Lewis T. Auricular fibrillation: A common clinical condition. Br Med J 1909;2:1528.
3. Lewis T. Observations upon flutter in fibrillation: Part IV. Impure flutter of circus movement. Heart 1920;7:293.
4. Godtfredsen J. Atrial fibrillation: Etiology, course and prognosis, a follow-up study of 1212 cases. Doctor of Medicine thesis, University of Copenhagen, Munksgaard, 1975.
5. Bejamin EJ, Levy D, Vasiri SM, D'Agostino RB, Belanger AJ, Wolf PA. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA 1994;271:840-844.
6. Krahn AD, Manfreda J, Tate RB, Mathewson F, Cuddy TE. The natural history of atrial fibrillation: Incidence, risk factors, and prognosis. The Manitoba Follow-up Study. Am J Med 1995;98:476-484.
7. Lake FR, McCall MG, Cullen KJ, Rosman DL, DeKlerk NH. Atrial fibrillation in mortality in an elderly population. Aust NZ J Med 1989;19:321-325.
8. Psaty BM, Manoliota, Kuller LH, Kronmal RA, Suchman M, Fried LP, White R, Furberg CD, Rautaharju PM. Incidence of and risk factors for atrial fibrillation in older adults. Circulation 1997;96:2455-2461.
9. The Manitoba Follow-up Study, unpublished data.
10. Fonarow GC, Chelimsky-Fallick C, Stevenson LW, et al. Effective direct vasodilatation with hydralazine versus angiotensin-converting enzyme inhibition with captopril on mortality in advanced heart failure: The Hy-C trial. J Am Coll Cardiol 1992;19:842-850.
11. Pitt B, Segal R, Martinez FA, et al. Randomized trial of losartan versus captropril in patients over 65 with heart failure (evaluation of losartan in the elderly study, ELITE). Lancet 1997;349:747-752.
12. Waldo AL, Henthorn RW, Epstein AE, Plumb VI. Diagnosis and treatment of arrhythmias during and following open heart surgery. Med Clin North Am 1984;68:1153-1169.
13. Goldman L. Supraventricular tachyarrhythmias in hospitalized adults after surgery: Clinical correlates in patients over years of age after major non-cardiac surgery. Chest 1978;73:450-454.
14. Sawin CT, Geller A, Wolf PA, et al. Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older adults. N Engl J Med 1994;331:1249-1252.
15. Brugada R, Tapscott T, Czernuszewicz, et al. Identification of a genetic locus for familial atrial fibrillation. N Engl J Med 1997;336:905-911. 16.
16. Moe JK. On the multiple wavelet hypothesis of atrial fibrillation. Arch Int Pharmacodyn Ther 1982;140:183-188.
17. West TC, Landa JF. Minimal mass required for induction of a sustained arrhythmia in isolated atrial segments. Am J Physiol 1962;202:232-236.
18. Vasiri SM, Larson MG, Benjamin EJ, Levy. Echocardiographic predictors of non-rheumatic atrial fibrillation. The Framingham Heart Study. Circulation 1994;89:724-730.
19. Henry WL, Morganroth J, Pearlman AS, Clark CE, Redwood DR, Itscoitz SV, Epstein SE. Relation between echocardiographically determined left atrial size and atrial fibrillation. Circulation 1976;53:273-279.
20. Frustaci A, Chimenti C, Bellocci F, Morgante E, Russo MA, Maseri A. Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation 1997;96: 1180-1184.
21. Sanfilippo AJ, Abascal VM, Sheeha M, Oertel LB, Harrigan P, Hughes RA, Weyman AE. Atrial enlargement as a consequence of atrial fibrillation: A prospective echocardiographic study. Circulation 1990;82:792-797.
22. Wijffels, MCEF, Kirchof CJHJ, Dorlend R, Allessie MA. Atrial fibrillation begets atrial fibrillation: A study in awake chronically instrumented goats. Circulation 1995;92: 1954-1968.
23. Fukunami M, Yamada T, Ohmori M, et al. Detection of patients at risk for paroxysmal atrial fibrillation during sinus rhythm by P-wave-triggered signal-averaged electrocardiogram. Circulation 1991;83:162-169.
24. Guidera SA, Steinberg JS. Signal-average P-wave duration: A rapid and non-evasive marker of risk of atrial fibrillation. J Am Coll Cardiol 1993;21:1645-1651.
25. Braunwald E, Frahm CJ. Studies on Starling's Law of the Heart IV: Observations on the hemodynamic functions of the left atrium in man. Circulation 1961;24:633-641.
26. Morris JJ, Entman M, North WC, Kong Y, McIntosh H. The changes in cardiac output with reversion of atrial fibrillation to sinus rhythm. Circulation 1965;31:670-678.
27. Gosselink ATM, Crijns HJGM, VanDenBerg MP, VanDen-Broek, SAJ, Hillege H, Landsman MLJ, Lie KI. Functional capacity before and after cardioversion of atrial fibrillation: A controlled study. Br Heart J 1994;72:161-166.
28. VanGelder IC, Crijns HJGM, Blanksma PK, et al. Time course of hemodynamic changes and improvement of exercise tolerance after cardio version of chronic atrial fibrillation unassociated with cardiac valve disease. Am J Cardiol 1993;72:560-566.
29. Carson PE, Johnson GR, Dunkman WB, Fletcher RD, Farrell L, Kohn JN. The influence of atrial fibrillation on prognosis in mild to moderate heart failure: The V-HeFT studies. Circulation 1993;87(Suppl.):VI102-VI110.
30. Daoud EG, Bogun F, Goyal R, Harvey M, ChingMan K, Strickberger SA, Morady F. Effect of atrial fibrillation on atrial refractoriness in humans. Circulation 1996;94: 1600-1606.
31. Gustafsson C, Blomback M, Britton M, Hamsten A, Svensson J. Coagulation factors and the increased risk of stroke in non-valvular atrial fibrillation. Stroke 1990;21:47-51.
32. Sohara H, Amitani S, Kurose M, Miyahara K. Atrial fibrillation activates platelets and coagulation in a time- dependent manner: A study in patients with paroxysmal atrial fibrillation. J Am Coll Cardiol 1997;29:106-112.
33. Gajewski J, Singer RB. Mortality in an insured population with atrial fibrillation. J Am Coll Cardiol 1981;245: 1540-1544.
34. Stafford WJ, Trohman RG, Bilsker M, Zaman L, Castellanos A, Myerburg, RJ. Cardiac arrest in an adolescent with atrial fibrillation and hypertrophic cardiomyopathy. J Am Coll Cardiol 1986;7:701-704.
35. Petersen P, Godtfredsen J. Embolic complications in paroxysmal atrial fibrillation. Stroke 1986;27:622-626.
36. Brand FN, Abbott RD, Kanel WB, Wolf PA. Characteristics and prognosis of lone atrial fibrillation - 30 year follow-up in the Framingham Study. J Am Coll Cardiol 1985;254: 3449-3453.
37. Kopecky SL, Gersh BJ, McGoon MD, Whisnat JP, Holmes DR, Ilstrup DM, Frye RL. The natural history of lone atrial fibrillation: A population-based study over three decades. N Engl J Med 1987;317:669-674.
38. Flegel KM, Shipley MJ, Rose G. Risk of stroke in non-rheumatic atrial fibrillation. Lancet 1987;1:526-529.
39. Laupacis A, Boysen G, Connolly S, et al. Risk factors for stroke and efficacy of antithrombotic theraphy in atrial fibrillation: Analysis of pooled data from five randomized controlled trials. Arch Intern Med 1994;154:1449-1457.
40. Stroke Prevention in Atrial Fibrillation Investigators. Adjusted dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high risk patients with atrial fibrillation: Stroke prevention in atrial fibrillation III a randomized clinical trial. Lancet 1996;348:633-638.
41. The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators: The effect of low-dose warfarin on the risk of stroke in patients with non-rheumatic atrial fibrillation. N Engl J Med 1990;323:1505-1511.
42. Aronow WS, Anh C, Gutstein H. Prevalence of atrial fibrillation and association of atrial fibrillation with prior and new thromboembolic stroke in older patients. J Am Geriatr Soc 1996;44:521-523.
43. Ezekowitz MD, James KE, Nazarian SM, et al. Silent cerebral infarction in patients with non-rheumatic atrial fibrillation: The Veterans Affairs Stroke Prevention in Non-rheumatic Atrial Fibrillation investigators. Circulation 1995;92: 2178-2182.
44. Lin HJ, Wolf PA, Benjamin EJ, Belanger HA, D'Agostino RB. Newly diagnosed atrial fibrillation and acute stroke: The Framingham Study. Stroke 1995;26:1527-1530.
45. Lanzarotti CJ, Olshansky B. Thromboembolism in chronic atrial fibrillation: Is the risk underestimated? J Am Coll Cardiol 1997;30:1506-1511.
46. Zieler A, Do A, Mick MJ, Mazureck RP, Loop FD, Trohman RG. Role of prophylactic anticoagulation for direct current cardioversion in patients with atrial fibrillation or atrial flutter. J Am Coll Cardiol 1992;19:851-855.
47. Grogan M, Sniff HC, Gersh BJ, Wood DL. Left ventricular dysfunction due to atrial fibrillation in patients initially believed to have idiopathic dilated cardiomyopathy. Am J Cardiol 1992;69:1570-1573.
48. Peters KG, Kienzle MG. Severe cardiomyopathy due to chronic rapidly conducted atrial fibrillation: Complete recovery after restoration of sinus rhythm. Am J Med 1988; 88:242-244.
49. Ewy GA, Ulfers L, Hager WD, Rosenfeld AR, Roeske WR, Goldman S. Response of atrial fibrillation to therapy: Role of etiology in left atrial diameter. J Electrocardiol 1980;13: 119-124.